Clinical Trial Update: REpositionable Percutaneous Replacement of NatIve StEnotic Aortic Valve Through Implantation of LOTUS EDGE Valve System [NA]

View source ↗

Summary

Boston Scientific's trial evaluating the LOTUS EDGE transcatheter aortic valve system for native aortic valve stenosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• LOTUS EDGE Valve System

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Aortic Valve Stenosis | NA | Status: TERMINATED